Growth Metrics

Vanda Pharmaceuticals (VNDA) EPS (Basic) (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Vanda Pharmaceuticals 379.35 Mn 177.04 Mn 48.56 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 65.69%
Dec 31, 2025 -528.95%
Sep 30, 2025 17.39%
Jun 30, 2025 8.00%
Mar 31, 2025 -455.56%
Dec 31, 2024 0.00%
Sep 30, 2024 -12.50%
Jun 30, 2024 -14.29%
Mar 31, 2024 -40.00%
Dec 31, 2023 -2,192.33%
Sep 30, 2023 -92.03%
Jun 30, 2023 -50.00%
Mar 31, 2023 -50.00%
Dec 31, 2022 100.00%
Sep 30, 2022 20.00%
Jun 30, 2022 145.45%
Mar 31, 2022 -184.62%
Dec 31, 2021 -7.14%
Sep 30, 2021 -17.65%
Jun 30, 2021 6.25%
Mar 31, 2021 6.67%
Dec 31, 2020 36.36%
Sep 30, 2020 -31.25%
Jun 30, 2020 1,500.00%
Mar 31, 2020 -87.50%
Dec 31, 2019 -95.74%
Sep 30, 2019 754.55%
Jun 30, 2019 2,300.00%
Mar 31, 2019 -105.00%
Dec 31, 2018 42.86%
Sep 30, 2018 55.56%
Jun 30, 2018 28.57%
Mar 31, 2018 275.00%
Dec 31, 2017 60.00%
Sep 30, 2017 -233.33%
Jun 30, 2017 82.35%
Mar 31, 2017 -1,600.00%
Dec 31, 2016 0.00%
Sep 30, 2016 90.91%
Jun 30, 2016 62.07%
Mar 31, 2016 14.71%
Dec 31, 2015 -54.55%
Sep 30, 2015 -69.23%
Jun 30, 2015 45.83%
Mar 31, 2015 -112.97%
Dec 31, 2014 4,725.00%
Sep 30, 2014 93.75%
Jun 30, 2014 18.99%
Mar 31, 2014 -243.48%
Dec 31, 2013 -35.29%
Sep 30, 2013 -41.67%
Jun 30, 2013 25.00%
Mar 31, 2013 30.43%
Dec 31, 2012 -21.05%
Sep 30, 2012 32.14%
Jun 30, 2012 0.00%
Mar 31, 2012 -40.00%
Dec 31, 2011 -81.82%
Sep 30, 2011 -120.00%
Jun 30, 2011 -1,133.14%
Mar 31, 2011 -93.95%
Dec 31, 2010 -27.27%
Sep 30, 2010 120.00%